Nexnos Pharma Limited - healthcare in Chittorgarh, Rajasthan, India. FY 2026 financials and compliance.
CIN U24100RJ2007PLC024845 Incorporated 14 August 2007 ROC Jaipur HQ Chittorgarh, Rajasthan, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2025
₹36.91 Cr
▲ 187.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1.91 Cr
Issued & subscribed
Open charges
₹12 Cr
Satisfied ₹12 Cr
Company age
19 yrs
Est. 2007
Last financials
Mar 2025
Balance sheet date

About Nexnos Pharma Limited

Data last updated: 21 December 2025

Nexnos Pharma Limited is a public limited company based in Chittorgarh, Rajasthan, India. It specialises in medical equipment retail and distribution, a part of the broader healthcare sector. Incorporated on 14 August 2007, the company has been in operation for over 19 years.

Registered with ROC Jaipur under CIN U24100RJ2007PLC024845.

Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.91 Cr. Formerly known as Asnani Brokers Private Limited and Nexnos Pharma Limited. It is led by directors including Kamal Asnani and Vinod Asnani.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.

As per the financials filed for FY 2025, the company reported a revenue of ₹36.91 Cr, reflecting significant growth compared to the previous year.

As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹12 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asnanionline.com.

Company Details of Nexnos Pharma Limited
CIN U24100RJ2007PLC024845
Registration Number 024845
Incorporation Date 14 August 2007
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Company report
Nexnos Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nexnos Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Nexnos Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Nexnos Pharma Limited

Nexnos Pharma Limited has undergone 2 name changes throughout its history. The company was previously known as Asnani Brokers Private Limited, and Nexnos Pharma Limited. The current legal name is Nexnos Pharma Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Nexnos Pharma Limited Current
Asnani Brokers Private Limited Previous

CIN History of Nexnos Pharma Limited

Nexnos Pharma Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100RJ2007PLC024845, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100RJ2007PLC024845 Current
U67120RJ2007PTC024845 Previous
U74110RJ2007PTC024845 Previous
U24100RJ2007PTC024845 Previous

Business Activity of Nexnos Pharma Limited

Nexnos Pharma Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Nexnos Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Nexnos Pharma Limited

Nexnos Pharma Limited is currently managed by 5 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Kamal Asnani Director 14 Aug 2007 19 Years 0 Months Current
Vinod Asnani Director 14 Aug 2007 19 Years 0 Months Current
Rajesh Peswani Director 20 Mar 2024 2 Years 4 Months Current
Rameshchandra Director 03 May 2023 3 Years 3 Months Current
Ashish Kumar Agrawal Director 03 May 2023 3 Years 3 Months Current

Financials of Nexnos Pharma Limited FY 2025 filings available

Nexnos Pharma Limited reported revenue of ₹36.91 Cr (up 187.00% YoY) for FY 2025.

Revenue · FY 2025
₹36.91 Cr ▲ 187.00%
Premium access

Ten-year financial statements for Nexnos Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nexnos Pharma Limited

Open charges
₹12 Cr
Satisfied charges
₹12 Cr
Breakdown by lending institutions
Others₹12.00 Cr
Latest charge details
DateLenderAmountStatus
19 Jun 2024 Others ₹12 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Nexnos Pharma Limited

View historical data on people associated with Nexnos Pharma Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Nexnos Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Nexnos Pharma Limited

Premium access

GST registrations and filing compliance for Nexnos Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Nexnos Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Nexnos Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nexnos Pharma Limited

Premium access

MSME payment history for Nexnos Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nexnos Pharma Limited

Premium access

Corporate group structure for Nexnos Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nexnos Pharma Limited

Premium access

MCA filings and documents for Nexnos Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Nexnos Pharma Limited

Charges
02 Dec 2025
A charge registered on 19 Jun 2024 via Charge ID 100936082 with Others was fully satisfied on 02 Dec 2025.
Activity
30 Sep 2025
Nexnos Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Nexnos Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
07 Nov 2024
A charge with Others of Rs. 12.00 Cr registered on 19 Jun 2024 with Charge ID 100936082 was modified on 07 Nov 2024.
Charges
19 Jun 2024
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100936082 was registered on 19 Jun 2024.
Directors
20 Mar 2024
Rajesh Peswani was appointed as a Director on 20 Mar 2024 & has been associated with this company since 2 years 5 months.

Frequently Asked Questions about Nexnos Pharma Limited

Nexnos Pharma Limited is an active public limited company in the healthcare sector based in Chittorgarh, Rajasthan, India. It was incorporated on 14 August 2007 (19+ years old) and is registered under CIN U24100RJ2007PLC024845.

Nexnos Pharma Limited reported revenue of ₹36.91 Cr for FY 2025 (up 187.00% YoY).

The current directors of Nexnos Pharma Limited are:

The primary industry of Nexnos Pharma Limited is healthcare. The company specifically operates in medical equipment retail and distribution. The company is currently active in this sector.

Nexnos Pharma Limited can be reached at the registered office: 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001, or through the website asnanionline.com.

The authorised capital is ₹5 Cr, and the paid-up capital is ₹1.91 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available